Private Equity

Updated:

Superorganism

Superorganism is the first venture firm dedicated to biodiversity, backing pre-seed and seed startups that disrupt the industries driving extinction.

Superorganism

Superorganism

Superorganism was founded in San Francisco by a five-partner team blending conservation science and startup operations. Tom Quigley brought a decade bridging technology and biodiversity, while Kevin Webb added over 15 years of marketplace and hardware investing. Co-founders Annie McCluskey, Kit McDonnell, and Everett Sanderson each contribute distinct career arcs—endowment management at National Geographic, biotech operating, and climate venture capital—that shape the firm's scientific and financial rigor. Superorganism writes first checks into pre-seed and seed companies that slow or reverse biodiversity loss. Its portfolio spans enabling technologies, climate-biodiversity overlaps, and direct extinction-driver disruption. Confirmed positions include Amini (environmental data infrastructure for Africa), Array Labs (3D satellite imagery), BluumBio (enzymatic pollution breakdown), Inversa (invasive-species leather), Planet A Foods (cocoa-free chocolate via biomanufacturing), and Funga (forest fungal microbiome rewilding). Geographically, the portfolio extends from North America to Africa, with sector exposure cutting across fintech, prop-tech, foodtech, synthetic biology, and atmospheric monitoring. The firm lists five named investment partners and a mentor network of 27 conservation and entrepreneurship leaders—figures such as Beth Shapiro, Keolu Fox, and Topher White—that provides portfolio founders on-demand domain guidance. Co-headquarters or additional offices are not disclosed. Superorganism has earmarked 10% of its profits for future conservation efforts, channeling carried interest into a nature funding gap initiative rather than standard charitable carve-outs. No AUM, fund size, or deployment total is publicly available. Superorganism functions as a thematically pure venture platform, not a diversified fund. Its explicit focus on biodiversity—and the requirement that every startup address an extinction driver—constitutes a structural hard edge uncommon in climate tech. The mentor network doubles as both a sourcing engine and a due-diligence layer, embedding ecological scientists and company builders into pipeline decisions directly. That operating model binds deal flow to academic and field-conservation networks, giving the firm access to founders outside standard SaaS and consumer deal circuits.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

San Francisco

Corporate office

San Francisco, CA, United States

Principals

Tom Quigley

Co-Founder

Kevin Webb

Co-Founder

Annie McCluskey

Co-Founder

Kit McDonnell

Co-Founder

Everett Sanderson

Co-Founder

Sector focus

ClimateTechAI/MLAgriTech & FoodTechIndustrial TechRobotics & AutomationEnterprise SoftwareSpaceTechMobility & TransportationLuxuryEnergy Transition & RenewablesPropTechBlue Economy

Frequently asked questions

Who makes investment decisions at Superorganism?

The five named co-founders—Tom Quigley, Kevin Webb, Annie McCluskey, Kit McDonnell, and Everett Sanderson—serve as the investment committee. Each brings distinct operational or conservation expertise; Quigley and Webb carry the longest tenures in tech-nature overlap, while McCluskey and Sanderson add institutional science-capital and climate-VC perspectives. The firm's mentor network appears to advise but does not vote on deals.

How does Superorganism source proprietary deal flow?

Superorganism draws pipeline through its 27-person mentor network of conservation technologists and serial entrepreneurs, which includes figures like Beth Shapiro, Topher White, and Keolu Fox. The firm also publishes a monthly biodiversity newsletter and maintains field-research partnerships that surface deep-tech founders working on extinction-driver problems—agriculture, infrastructure monitoring, atmospheric intervention—before they appear at traditional climate-tech demo days.

Does Superorganism participate in fund commitments or only direct deals?

All disclosed activity points to direct pre-seed and seed equity investments. The firm has not indicated any fund-of-funds commitments or LP positions in other venture vehicles. Portfolio companies like Amini, Planet A Foods, and Inversa are structured as direct holdings.

What investment stages does Superorganism target?

Superorganism concentrates on pre-seed and seed rounds, providing first institutional capital to startups at the earliest inflection point. The portfolio companies—such as Spoor (AI for bird detection at wind farms) and Ulysses (kilometer-scale seagrass restoration)—exhibit the technology-readiness levels typical of companies that have moved beyond laboratory proof-of-concept and need initial go-to-market funding.

How is Superorganism related to the conservation non-profit world?

The firm pledges 10% of its own profits to future conservation initiatives, though it is structured as a for-profit venture manager rather than a hybrid impact vehicle. The pledge does not create a separate 501(c)(3) entity; instead it earmarks carried interest and management-company profits for nature funding. The mentor network includes conservation researchers and practitioners, but retains no formal governance rights over investment decisions.

What is Superorganism's known posture on co-investments alongside external GPs?

Superorganism has not publicly structured a formal co-investment program or disclosed sidecar vehicles. Given the pre-seed and seed focus, rounds likely include syndicates with other climate- and biodiversity-focused micro-funds and angel investors, but the firm's website and public disclosures do not name recurring syndicate partners.

Which sectors does Superorganism explicitly avoid?

The firm's biodiversity mandate creates a negative screen against companies that exacerbate extinction drivers without a measurable remediation or disruption angle. Traditional extractive industries, industrial agriculture without regenerative transition roadmaps, and pure software plays that do not intersect with biodiversity outcomes would fall outside its stated scope. No explicit restricted-sector list is published, but the investment thesis filters out any startup that does not materially address an extinction driver.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo